Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 16049 | 609 | 34.0 | 59% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 994 | 9968 | IDIOPATHIC PULMONARY FIBROSIS//USUAL INTERSTITIAL PNEUMONIA//PULMONARY ALVEOLAR PROTEINOSIS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PULMONARY RHEUMATOID NODULE | Author keyword | 4 | 75% | 0% | 3 |
| 2 | RHEUMATOID LUNG | Author keyword | 4 | 75% | 0% | 3 |
| 3 | RHEUMATOID PLEURITIS | Author keyword | 4 | 75% | 0% | 3 |
| 4 | LE CELLS | Author keyword | 3 | 50% | 1% | 4 |
| 5 | NODULOSIS | Author keyword | 2 | 44% | 1% | 4 |
| 6 | PULMONARY RHEUMATOID NODULES | Author keyword | 2 | 67% | 0% | 2 |
| 7 | COLLAGEN VASCULAR DISEASES | Author keyword | 2 | 19% | 1% | 8 |
| 8 | ANTI CYCLIC CITRULLINATED ANTIBODIES | Author keyword | 1 | 50% | 0% | 2 |
| 9 | TART CELLS | Author keyword | 1 | 100% | 0% | 2 |
| 10 | CAPLANS SYNDROME | Author keyword | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PULMONARY RHEUMATOID NODULE | 4 | 75% | 0% | 3 | Search PULMONARY+RHEUMATOID+NODULE | Search PULMONARY+RHEUMATOID+NODULE |
| 2 | RHEUMATOID LUNG | 4 | 75% | 0% | 3 | Search RHEUMATOID+LUNG | Search RHEUMATOID+LUNG |
| 3 | RHEUMATOID PLEURITIS | 4 | 75% | 0% | 3 | Search RHEUMATOID+PLEURITIS | Search RHEUMATOID+PLEURITIS |
| 4 | LE CELLS | 3 | 50% | 1% | 4 | Search LE+CELLS | Search LE+CELLS |
| 5 | NODULOSIS | 2 | 44% | 1% | 4 | Search NODULOSIS | Search NODULOSIS |
| 6 | PULMONARY RHEUMATOID NODULES | 2 | 67% | 0% | 2 | Search PULMONARY+RHEUMATOID+NODULES | Search PULMONARY+RHEUMATOID+NODULES |
| 7 | COLLAGEN VASCULAR DISEASES | 2 | 19% | 1% | 8 | Search COLLAGEN+VASCULAR+DISEASES | Search COLLAGEN+VASCULAR+DISEASES |
| 8 | ANTI CYCLIC CITRULLINATED ANTIBODIES | 1 | 50% | 0% | 2 | Search ANTI+CYCLIC+CITRULLINATED+ANTIBODIES | Search ANTI+CYCLIC+CITRULLINATED+ANTIBODIES |
| 9 | TART CELLS | 1 | 100% | 0% | 2 | Search TART+CELLS | Search TART+CELLS |
| 10 | CAPLANS SYNDROME | 1 | 40% | 0% | 2 | Search CAPLANS+SYNDROME | Search CAPLANS+SYNDROME |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | METHOTREXATE PNEUMONITIS | 8 | 50% | 2% | 12 |
| 2 | EXTRAARTICULAR MANIFESTATIONS | 7 | 23% | 4% | 26 |
| 3 | ACCELERATED NODULOSIS | 6 | 31% | 2% | 15 |
| 4 | NONSMOKING PATIENTS | 6 | 100% | 1% | 4 |
| 5 | SMALL AIRWAYS FUNCTION | 4 | 67% | 1% | 4 |
| 6 | COLLAGEN VASCULAR DISEASES | 4 | 17% | 3% | 20 |
| 7 | FIBROSING ALVEOLITIS | 4 | 11% | 5% | 30 |
| 8 | COLLAGEN VASCULAR DISEASE | 3 | 17% | 3% | 17 |
| 9 | HRCT FINDINGS | 3 | 50% | 1% | 4 |
| 10 | METHOTREXATE INDUCED PNEUMONITIS | 2 | 28% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| PULMONARY INVOLVEMENT IN RHEUMATOID-ARTHRITIS | 1995 | 109 | 57 | 56% |
| Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases | 2011 | 52 | 44 | 27% |
| Pulmonary manifestations of rheumatoid arthritis | 1998 | 52 | 87 | 51% |
| Predictors of mortality in rheumatoid arthritis-related interstitial lung disease | 2014 | 6 | 26 | 42% |
| Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review | 2014 | 9 | 96 | 31% |
| Lung disease in rheumatoid arthritis | 2008 | 33 | 56 | 43% |
| Interstitial Lung Disease in Patients with Rheumatoid Arthritis: Spontaneous and Drug Induced | 2014 | 2 | 69 | 61% |
| Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD) | 2013 | 4 | 80 | 45% |
| Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis | 2013 | 4 | 71 | 41% |
| Occurrence of pulmonary rheumatoid nodules following biological therapies | 2015 | 0 | 6 | 83% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AUTOIMMUNE INTERSTITIAL LUNG DIS PROGRAM | 1 | 50% | 0.2% | 1 |
| 2 | CLIN PHYS MED REHABIL 2 | 1 | 50% | 0.2% | 1 |
| 3 | CLIN RADIOL IMAGING | 1 | 50% | 0.2% | 1 |
| 4 | HPRHEUMATOL B | 1 | 50% | 0.2% | 1 |
| 5 | NACL ENFERMEDADES P CIRUGIA TORAC | 1 | 50% | 0.2% | 1 |
| 6 | PROGRAMA BECARIOS INVEST | 1 | 50% | 0.2% | 1 |
| 7 | PROGRAMA INT MED | 1 | 50% | 0.2% | 1 |
| 8 | PROGRAMA MAESTRIA CIENCIAS MED | 1 | 50% | 0.2% | 1 |
| 9 | PROGRAMA SERV SOCIAL INVEST | 1 | 50% | 0.2% | 1 |
| 10 | RHEUMATOLMEYERS PRIMARY CARE | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000265403 | SHRINKING LUNG SYNDROME//IDIOPATHIC PULMONARY HEMOSIDEROSIS//PULMONARY HEMOSIDEROSIS |
| 2 | 0.0000245713 | BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA//CRYPTOGENIC ORGANIZING PNEUMONIA//ORGANIZING PNEUMONIA |
| 3 | 0.0000201434 | RHEUMATOID VASCULITIS//RHEUMATOID MYOSITIS//EXTRAARTICULAR MANIFESTATIONS |
| 4 | 0.0000137302 | IDIOPATHIC PULMONARY FIBROSIS//USUAL INTERSTITIAL PNEUMONIA//IDIOPATHIC INTERSTITIAL PNEUMONIA |
| 5 | 0.0000130727 | CRICOARYTENOID ARTHRITIS//LARYNGEAL SARCOIDOSIS//SINONASAL SARCOIDOSIS |
| 6 | 0.0000125968 | CHRONIC EOSINOPHILIC PNEUMONIA//ACUTE EOSINOPHILIC PNEUMONIA//EOSINOPHILIC PNEUMONIA |
| 7 | 0.0000108149 | METHOTREXATE//METHOTREXATE POLYGLUTAMATES//MX 68 |
| 8 | 0.0000106796 | PULMONARY TOXICITY//PULM DIS INTENS CARE//GEFITINIB IRESSA |
| 9 | 0.0000090067 | GRANULOMA ANNULARE//NECROBIOSIS LIPOIDICA//SUBCUTANEOUS GRANULOMA ANNULARE |
| 10 | 0.0000085079 | KL 6//KREBS VON DEN LUNGEN 6//BIOLOGICAL DISEASE MODIFYING ANTIRHEUMATIC DRUG |